Showing results (261-270 of 496) with videos related to

Sort By:
Pageof 50
Progress in Neurobiology|March 24, 2005
Neuromelanin in human dopamine neurons: comparison with peripheral melanins and relevance to Parkinson's diseaseH Fedorow, F Tribl, G Halliday, et al.
Dementia and Geriatric Cognitive Disorders|February 15, 2001
Abnormal localization of two neuronal calcium sensor proteins, visinin-like proteins (vilips)-1 and -3, in neocortical brain areas of Alzheimer disease patientsK Braunewell, P Riederer, C Spilker, et al.
Neuropharmacology|July 1, 1995
Therapeutic brain concentration of the NMDA receptor antagonist amantadineJ Kornhuber, G Quack, W Danysz, et al.
Neuroscience Letters|October 24, 1994
Interleukin-1 beta, interleukin-6, epidermal growth factor and transforming growth factor-alpha are elevated in the brain from parkinsonian patientsM Mogi, M Harada, T Kondo, et al.
Annals of Neurology|May 1, 1986
Dopamine D2 receptor density remains constant in treated Parkinson's diseaseM Guttman, P Seeman, G P Reynolds, et al.
Psychiatry Research|December 1, 1990
Glucocorticoid receptors on mononuclear leukocytes in Alzheimer's diseaseR Rupprecht, L Frölich, T Mergenthaler, et al.
Neuroscience Letters|December 20, 1996
The soluble form of Fas molecule is elevated in parkinsonian brain tissuesM Mogi, M Harada, T Kondo, et al.
European Journal of Pharmacology|July 6, 1993
Nimodipine inhibits [3H]nitrobenzylthioinosine binding to the adenosine transporter in human brainJ Deckert, B Bereznai, A Hennemann, et al.
Neuroscience Letters|September 6, 1996
bcl-2 protein is increased in the brain from parkinsonian patientsM Mogi, M Harada, T Kondo, et al.
Brain Research|May 29, 1998
Measurement of receptor-mediated functional activation of G proteins in postmortem human brain membranesY Odagaki, N Nishi, H Ozawa, et al.
Pageof 50